2017 International Meeting on the Molecular Biology of Hepatitis B Viruses

2017年乙型肝炎病毒分子生物学国际会议

• 批准号: 9330983
• 负责人: Timothy M Block
• 金额: $ 0.63万
• 依托单位: HEPATITIS B FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-08-15 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9330983
• 关键词: Address; Animal Model; Anniversary; Antiviral Agents; Antiviral Therapy; Basic Science; Biochemistry; Biology; Biomedical Research; Cellular biology; Cessation of life; Chronic; Circular DNA; Cirrhosis; Communities; Development; Discipline; Disease; District of Columbia; Financial Support; Foundations; Fund Raising; Funding; Future; Gene Expression; Goals; Grant; Hepatitis B; Hepatitis Delta Virus; Home environment; Immunology; Individual; Infection; International; Joints; Knowledge; Light; Liver Failure; Liver diseases; Malignant Neoplasms; Mission; Modality; Molecular Biology; National Cancer Institute; National Institute of Allergy and Infectious Disease; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; Oral; Pathogenesis; Population; Postdoctoral Fellow; Preventive vaccine; Primary carcinoma of the liver cells; Public Health; RNA Editing; Regulatory Element; Research; Research Personnel; Schedule; Scientist; Senior Scientist; Structure; Supervision; Therapeutic; Time; Travel; Underrepresented Minority; United States National Institutes of Health; Universities; Vaccines; Viral; Virus; Virus Diseases; Virus Shedding; cost; gene therapy; graduate student; interest; lecturer; meetings; minority investigator; pathogen; posters; protein expression; symposium; vector; virology; virus pathogenesis; Address; Animal Model; Anniversary; Antiviral Agents; Antiviral Therapy; Basic Science; Biochemistry; Biology; Biomedical Research; Cellular biology; Cessation of life; Chronic; Circular DNA; Cirrhosis; Communities; Development; Discipline; Disease; District of Columbia; Financial Support; Foundations; Fund Raising; Funding; Future; Gene Expression; Goals; Grant; Hepatitis B; Hepatitis Delta Virus; Home environment; Immunology; Individual; Infection; International; Joints; Knowledge; Light; Liver Failure; Liver diseases; Malignant Neoplasms; Mission; Modality; Molecular Biology; National Cancer Institute; National Institute of Allergy and Infectious Disease; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; Oral; Pathogenesis; Population; Postdoctoral Fellow; Preventive vaccine; Primary carcinoma of the liver cells; Public Health; RNA Editing; Regulatory Element; Research; Research Personnel; Schedule; Scientist; Senior Scientist; Structure; Supervision; Therapeutic; Time; Travel; Underrepresented Minority; United States National Institutes of Health; Universities; Vaccines; Viral; Virus; Virus Diseases; Virus Shedding; cost; gene therapy; graduate student; interest; lecturer; meetings; minority investigator; pathogen; posters; protein expression; symposium; vector; virology; virus pathogenesis

2017 International HBV Meeting Project Summary/Abstract In this proposal, we request for funding to support the travel expenses for young scientists to attend and participate in the 2017 International Meeting on the Molecular Biology of Hepatitis B Viruses, scheduled for September 3-7, 2017 at the Omni Shoreham Conference Center and Hotel, Washington DC. This meeting is the only forum that gathers the international community of researchers that focus on the hepatitis B virus (HBV) and the closely associated hepatitis delta virus (HDV). Approximately 25% of the world's population has been infected by HBV. Unfortunately, despite the availability of prophylactic vaccines, many new infections occur worldwide, mostly because of underutilization of the vaccine due to cost and other issues. Moreover, for the approximately 350 million people already chronically infected with HBV (approximately 15 million of whom are co-infected with HDV), the vaccine is of no therapeutic value. As a result, between 0.5 and 1 million people die of HBV/HDV every year worldwide. It is therefore imperative that basic research on HBV continues, and the latest progress in the field is discussed and disseminated in a timely manner. The annual HBV meeting provides the forum for scientific exchanges and the dissemination of latest research information. The 2017 meeting will uphold and enhance the traditional format. It will consist of 8 oral scientific sessions and 2 poster sessions as well as less structured “networking” time. The scientific interactions will be facilitated by 3-4 keynote addresses. As in the past, great effort has been made to minimize the cost of the meeting. Furthermore, the Hepatitis B Foundation has made a strong commitment to support this meeting since 2005, in terms of providing a permanent home for organizing the meeting and making its staff available for supervising the meeting and publicizing it, especially to universities with large numbers of underrepresented minorities. In order to allow the participation of junior and minority investigators, support from the NIH to help defray the meeting costs is requested. It is expected that 300-400 attendees will register for the 2017 HBV meeting, which will mark the 33rd anniversary of the HBV meeting.

2017年国际HBV会议项目摘要/摘要 在此提案中，我们要求提供资金，以支持年轻科学家参加和 参加2017年国际丙型肝炎病毒分子生物学国际会议 2017年9月3日至7日在华盛顿特区的Omni Shoreham会议中心和酒店。这次会议是 唯一聚集着专注于丙型肝炎病毒（HBV）的国际研究人员社会的论坛 以及密切相关的肝炎三角病病毒（HDV）。大约25％的世界人口是 由HBV感染。不幸的是，尽管有预防性疫苗的可用性，但发生了许多新的感染 在全球范围内，主要是由于成本和其他问题而导致的疫苗的基本化。而且，为了 大约3.5亿人已经长期感染了HBV（其中约1500万人 与HDV共感染，该疫苗没有治疗值。结果，有0.5至100万人死亡 每年在全球范围内HBV/HDV。因此，对HBV的基础研究必须继续进行，并且 及时讨论和传播该领域的最新进展。年度HBV会议 提供了科学交流和传播最新研究信息的论坛。 2017年 会议将维持和增强传统格式。它将由8个口头科学会议和2个海报组成 会话以及结构较少的“网络”时间。科学互动将由3-4制备 主题演讲。与过去一样，已经做出了巨大的努力来最大程度地减少会议的成本。 此外，自2005年以来，乙型肝炎基金会一直致力于支持这次会议 为组织会议提供永久住所的条款，并使其员工可以进行监督 会议和发布会议，尤其是针对人数不足的少数民族的大学。在 为了允许初级和少数民族调查员的参与，NIH的支持以帮助支配 要求会议费用。预计有300-400名参加者将注册2017 HBV会议，该会议 将纪念HBV会议33周年。